Umazume, Akihiko
Ohguro, Nobuyuki
Okada, Annabelle A.
Namba, Kenichi
Sonoda, Koh-Hei
Tsuruga, Hidekazu
Morita, Kazuo
Goto, Hiroshi
Funding for this research was provided by:
AbbVie GK
Article History
Received: 27 November 2020
Accepted: 28 May 2021
First Online: 28 June 2021
Declarations
:
: A. Umazume, None; N. Ohguro, None; A. A. Okada, Grants (Bayer, Novartis, Santen, Mitsubishi Tanabe, Alcon), Consulting fees (Bayer, AbbVie, Astellas, Biocon Biologics, Daiichi Sankyo, Allergan, Chugai), Lecture fees (Bayer, Kowa, Novartis, Santen, Mitsubishi Tanabe, Senju, Alcon, Otsuka); K. Namba, Grant (AbbVie, Mitsubishi Tanabe, Eisai, EP-CRSU), Lecture fee (Alcon, Pfizer, Novartis, Kowa, Senju, Mitsubishi Tanabe, Eisai, AbbVie, Santen, Celgene); K. Sonoda, None; H. Goto, None; H. Tsuruga and K. Morita are employees of AbbVie GK and may receive stock.